These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 1373754

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Soluble CD14 and lipopolysaccharide-binding protein from bovine serum enable bacterial lipopolysaccharide-mediated cytotoxicity and activation of bovine vascular endothelial cells in vitro.
    Yang Z, Breider MA, Carroll RC, Miller MS, Bochsler PN.
    J Leukoc Biol; 1996 Feb; 59(2):241-7. PubMed ID: 8603996
    [Abstract] [Full Text] [Related]

  • 3. Soluble CD14 participates in the response of cells to lipopolysaccharide.
    Frey EA, Miller DS, Jahr TG, Sundan A, Bazil V, Espevik T, Finlay BB, Wright SD.
    J Exp Med; 1992 Dec 01; 176(6):1665-71. PubMed ID: 1281215
    [Abstract] [Full Text] [Related]

  • 4. In vitro cytotoxicity of Haemophilus influenzae lipopolysaccharides for bovine aortal endothelial cells.
    Langford PR, Szabo M, Moxon ER.
    FEMS Microbiol Lett; 1991 Jun 15; 65(2):161-4. PubMed ID: 1884991
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lipopolysaccharide induces apoptosis in a bovine endothelial cell line via a soluble CD14 dependent pathway.
    Frey EA, Finlay BB.
    Microb Pathog; 1998 Feb 15; 24(2):101-9. PubMed ID: 9480792
    [Abstract] [Full Text] [Related]

  • 8. Lipopolysaccharide (LPS)-binding protein and soluble CD14 function as accessory molecules for LPS-induced changes in endothelial barrier function, in vitro.
    Goldblum SE, Brann TW, Ding X, Pugin J, Tobias PS.
    J Clin Invest; 1994 Feb 15; 93(2):692-702. PubMed ID: 7509346
    [Abstract] [Full Text] [Related]

  • 9. Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells.
    Read MA, Cordle SR, Veach RA, Carlisle CD, Hawiger J.
    Proc Natl Acad Sci U S A; 1993 Nov 01; 90(21):9887-91. PubMed ID: 7694295
    [Abstract] [Full Text] [Related]

  • 10. A critical role for monocytes and CD14 in endotoxin-induced endothelial cell activation.
    Pugin J, Ulevitch RJ, Tobias PS.
    J Exp Med; 1993 Dec 01; 178(6):2193-200. PubMed ID: 7504060
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Anti-CD14 antibodies reduce responses of cultured human endothelial cells to endotoxin.
    von Asmuth EJ, Dentener MA, Bazil V, Bouma MG, Leeuwenberg JF, Buurman WA.
    Immunology; 1993 Sep 01; 80(1):78-83. PubMed ID: 7503948
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Fructose-1,6-bisphosphate ameliorates lipopolysaccharide-induced dysfunction of blood-brain barrier.
    Seok SM, Kim JM, Park TY, Baik EJ, Lee SH.
    Arch Pharm Res; 2013 Sep 01; 36(9):1149-59. PubMed ID: 23604722
    [Abstract] [Full Text] [Related]

  • 16. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42, and p41 in vascular endothelial cells in a soluble CD14-dependent manner. Role of protein tyrosine phosphorylation in lipopolysaccharide-induced stimulation of endothelial cells.
    Arditi M, Zhou J, Torres M, Durden DL, Stins M, Kim KS.
    J Immunol; 1995 Oct 15; 155(8):3994-4003. PubMed ID: 7561108
    [Abstract] [Full Text] [Related]

  • 17. The antibody MY4 recognizes CD14 on porcine monocytes and macrophages.
    Ziegler-Heitbrock HW, Appl B, Käfferlein E, Löffler T, Jahn-Henninger H, Gutensohn W, Nores JR, McCullough K, Passlick B, Labeta MO.
    Scand J Immunol; 1994 Nov 15; 40(5):509-14. PubMed ID: 7526441
    [Abstract] [Full Text] [Related]

  • 18. Haemophilus influenzae outer membrane vesicle-induced blood-brain barrier permeability during experimental meningitis.
    Wispelwey B, Hansen EJ, Scheld WM.
    Infect Immun; 1989 Aug 15; 57(8):2559-62. PubMed ID: 2787292
    [Abstract] [Full Text] [Related]

  • 19. Blood-brain barrier alterations in bacterial meningitis: development of an in vitro model and observations on the effects of lipopolysaccharide.
    Tunkel AR, Rosser SW, Hansen EJ, Scheld WM.
    In Vitro Cell Dev Biol; 1991 Feb 15; 27A(2):113-20. PubMed ID: 1826902
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.